Latest Press Releases

Arla Foods Ingredients and Brenntag Expand Collaboration into Southeast Asia

AARHUS, Denmark, May 20, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients has extended its distribution partnership with the Brenntag Group to include Southeast Asia’s three largest food and nutrition markets. The expanded collaboration will ...

Philips Launches Real-time 3d Intracardiac Imaging in Europe, Expanding Access to Minimally Invasive Heart Procedures

May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D ...

MIT, University of Colorado Denver, and Clue App Publish Largest Women's Health Study Documenting Air Pollution's Impact on Menstrual Cycles

CAMBRIDGE, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Researchers at MIT’s Senseable City Lab and the University of Colorado Denver , in collaboration with the Clue app, have published the largest study of its kind examining the impact ...

Magstim Granted EU MDR Certification

Magstim Passes Compliance with Strict European Union Medical Device RegulationsExpanding Magstim Access to Entire EU Marketplace WHITLAND, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Magstim has been granted EU MDR Certification for all ...

Philips Successfully Prices Offering of Notes for EUR 1 billion to be Used for Repayment of Existing debt and to Finance Eligible Green Projects

May 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million ...

Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension

PR Newswire PALO ALTO, Calif., FRANKFURT, Germany, May 17, 2025 World Hypertension Day's focus on High Blood Pressure Awareness, Management and Control highlights Importance of New Therapies, like Ultrasound Renal Denervation from Recor ...

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

PR Newswire WUXI, China and SHANGHAI, May 16, 2025 WUXI, China and SHANGHAI, May 16, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its ...

2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH

PR Newswire SHANGHAI, May 16, 2025 ——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-ß Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 16, 2025 /PRNewswire/ -- At the European ...

Alzheimer's Association Statement on First Blood Test Used in Diagnosing Alzheimer's Disease Cleared for Use by FDA

PR Newswire CHICAGO, May 16, 2025 CHICAGO, May 16, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has cleared the first blood test to aid in diagnosis of Alzheimer's disease. The test detects amyloid plaques, a hallmark of ...

Faith Leaders Organize for No Menthol Sunday

PR Newswire SAN FRANCISCO, May 16, 2025 SAN FRANCISCO, May 16, 2025 /PRNewswire/ -- The national movement to remove menthol cigarettes from the U.S. market continues, and the African American Tobacco Control Leadership Council (AATCLC) and ...

International Surgical Sleep Society Endorses Hyoid Suspension for Sleep Apnea Treatment

PR Newswire LOS GATOS, Calif., May 16, 2025 AIRLIFT® Emerges as the most effective, FDA-Cleared Hyoid Suspension System for Managing Obstructive Sleep Apnea LOS GATOS, Calif., May 16, 2025 /PRNewswire/ -- Following a rigorous review of ...

Lamassu Biotech Collaborates With The Ohio State University To Study New Therapy For Man And Man's Best Friend

PR Newswire CLEVELAND, May 16, 2025 Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man's Best Friend CLEVELAND, May 16, 2025 /PRNewswire/ -- Man's best friend may soon ...

Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia

PR Newswire SAN DIEGO, May 16, 2025 SAN DIEGO, May 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new analyses from a Phase 4 randomized withdrawal study (NCT03891862) showing ...

Interim Clinical Results for EndoZip™ Presented at IFSO-EC 2025 Congress Show Promising Safety Profile and Potential Benefits for Patients With Comorbidities

PR Newswire CAESAREA, Israel, May 16, 2025 Automated Endoscopic Approach Evaluated for Patients with Obesity, Hypertension, and Type 2 Diabetes CAESAREA, Israel, May 16, 2025 /PRNewswire/ -- Nitinotes, developer of EndoZip™, a fully ...

Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy

PR Newswire HELSINKI and BOSTON, May 16, 2025 HELSINKI and BOSTON, May 16, 2025 /PRNewswire/ -- Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital ...

Xuanzhu Biopharm's Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment

PR Newswire HONG KONG, May 15, 2025 HONG KONG, May 15, 2025 /PRNewswire/ -- On May 15, 2025, the latest announcement released by the National Medical Products Administration attracted widespread attention in the oncology community and the ...

ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis (IPF)

PR Newswire SHANGHAI, May 16, 2025 SHANGHAI, May 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of ...

Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)

PR Newswire SAN FRANCISCO and SUZHOU, China, May 15, 2025 SAN FRANCISCO and SUZHOU, China, May 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...

Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments | DelveInsight

PR Newswire LAS VEGAS, May 15, 2025 The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals), tezepelumab ...

Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™ (crinecerfont)

PR Newswire SAN DIEGO, May 15, 2025 SAN DIEGO, May 15, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 3 CAHtalyst™ Adult and Pediatric studies of CRENESSITY™ (crinecerfont). The data ...

P-Cure Announces FDA Clearance Expansion for Full-Body and Supine Proton Therapy Treatments

PR Newswire SHILAT, Israel, May 15, 2025 FDA clearance for P-Cure now includes full-body indications and supine treatment positions, significantly expanding clinical versatility and patient access SHILAT, Israel, May 15, 2025 ...

World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children's Hospital of Philadelphia

PR Newswire PHILADELPHIA and NEW ORLEANS, May 15, 2025 Landmark Study from CHOP and Penn Medicine Showcases the Power of Customized Gene Editing Therapy to Treat Patient with Rare Metabolic Disease PHILADELPHIA and NEW ORLEANS, May 15, ...

SparX Biopharmaceutical Corp Announces Research Agreement with Mitsubishi Tanabe Pharma America to Advance Novel Antibody-Drug Conjugates

PR Newswire CHICAGO, May 15, 2025 CHICAGO, May 15, 2025 /PRNewswire/ -- SparX Biopharmaceutical Corp ("SparX"), a clinical-stage biotechnology company pioneering next-generation antibody-drug conjugate (ADC) technologies, today announced the ...

BiaCure Therapies Awarded SBIR Phase I Grant to Advance Development of High-Frequency Energy Technology for the Treatment of Onychomycosis

PR Newswire PEWAUKEE, Wis., May 15, 2025 PEWAUKEE, Wis., May 15, 2025 /PRNewswire/ -- BiaCure Therapies, an emerging innovator in non-invasive medical technology, today announced it has been awarded a Small Business Innovation Research ...

What Women Should Know About Their Heart, Kidney and Metabolic Health

PR Newswire MISSION, Kan., May 15, 2025 MISSION, Kan., May 15, 2025 /PRNewswire/ -- (Family Features) Some women may be unaware they're living with risks for heart disease, kidney disease and metabolic conditions like diabetes, which drive ...

Noster research: Gut bacteria-derived molecule found to shrink fat cells and improve metabolism

PR Newswire KYOTO, Japan, May 14, 2025 KYOTO, Japan, May 14, 2025 /PRNewswire/ -- Joint study by University of Shizuoka, Kobe University, and Noster Inc. uncovers a novel postbiotic pathway for obesity prevention. A new ...

Kaerus Bioscience's lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS)

PR Newswire LONDON, May 14, 2025 LONDON, May 14, 2025 /PRNewswire/ -- Kaerus Bioscience ("Kaerus" or "the Company"), a clinical stage biopharmaceutical company created by Medicxi for the development of therapeutics for rare genetic syndromes ...

TENA Survey Reveals the Hidden Emotional Toll of Urinary Incontinence

PR Newswire PHILADELPHIA, May 14, 2025 PHILADELPHIA , May 14, 2025 /PRNewswire/ -- A new survey of 2,000 Americans by TENA, a leading incontinence brand, highlights the daily struggles of those living with UI – from how it impacts their ...

Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat

PR Newswire TAIPEI, May 14, 2025 TAIPEI, May 14, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) today announced the successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) for CBL-514, the ...

New report highlights shortfalls in neonatal care for mothers and infants across U.S.

PR Newswire PHOENIX, May 13, 2025 Air Evac is setting the gold standard in Arizona, providing specialist emergency 'in-air' perinatal care to the communities of Arizona • Air Evac is Arizona's premier Neonatal Intensive Care Unit (NICU) ...

L2 Bio, FDA Approves Crohn's Disease Trial as a Phase 2b Utilizing Adipose-Derived Stem Cells

PR Newswire HENDERSON, Nev., May 13, 2025 FDA has approved an aggressive stem cell clinical trial, offering potential new relief through intravenous (IV) administration. HENDERSON, Nev., May 13, 2025 /PRNewswire-PRWeb/ -- "We at L2 Bio ...

Liver Fibrosis Market to Witness Rapid Growth at a CAGR of ~24% During the Forecast Period (2025-2034) with Emerging Treatment Options | DelveInsight

PR Newswire LAS VEGAS, May 13, 2025 DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market size during the study period (2020–2034). This anticipated ...

Latest Press Releases

Premium Press Releases »

Arla Foods Ingredients and Brenntag Expand Collaboration into Southeast Asia

Philips Launches Real-time 3d Intracardiac Imaging in Europe, Expanding Access to Minimally Invasive Heart Procedures

MIT, University of Colorado Denver, and Clue App Publish Largest Women's Health Study Documenting Air Pollution's Impact on Menstrual Cycles

Magstim Granted EU MDR Certification

Philips Successfully Prices Offering of Notes for EUR 1 billion to be Used for Repayment of Existing debt and to Finance Eligible Green Projects

Press Releases »

Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH

Alzheimer's Association Statement on First Blood Test Used in Diagnosing Alzheimer's Disease Cleared for Use by FDA

Faith Leaders Organize for No Menthol Sunday

International Surgical Sleep Society Endorses Hyoid Suspension for Sleep Apnea Treatment

Lamassu Biotech Collaborates With The Ohio State University To Study New Therapy For Man And Man's Best Friend

Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia

Interim Clinical Results for EndoZip™ Presented at IFSO-EC 2025 Congress Show Promising Safety Profile and Potential Benefits for Patients With Comorbidities

Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy

Xuanzhu Biopharm's Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment

ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)

Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments | DelveInsight

Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™ (crinecerfont)

P-Cure Announces FDA Clearance Expansion for Full-Body and Supine Proton Therapy Treatments

World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children's Hospital of Philadelphia

SparX Biopharmaceutical Corp Announces Research Agreement with Mitsubishi Tanabe Pharma America to Advance Novel Antibody-Drug Conjugates

BiaCure Therapies Awarded SBIR Phase I Grant to Advance Development of High-Frequency Energy Technology for the Treatment of Onychomycosis

What Women Should Know About Their Heart, Kidney and Metabolic Health

Noster research: Gut bacteria-derived molecule found to shrink fat cells and improve metabolism

Kaerus Bioscience's lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS)

TENA Survey Reveals the Hidden Emotional Toll of Urinary Incontinence

Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat

New report highlights shortfalls in neonatal care for mothers and infants across U.S.

L2 Bio, FDA Approves Crohn's Disease Trial as a Phase 2b Utilizing Adipose-Derived Stem Cells

Liver Fibrosis Market to Witness Rapid Growth at a CAGR of ~24% During the Forecast Period (2025-2034) with Emerging Treatment Options | DelveInsight

Footprints to Recovery Launches New Inpatient Mental Health Treatment Program in Elgin, Illinois

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH

The Obesity Association Publishes the Standards of Care in Overweight and Obesity

Medindia Newsletters